Company intelligence / Profile preview

The Pirbright Institute

Pirbright/Woking/Surrey, England, United Kingdompirbright.ac.uk ↗

Ownership: Private
Employees: ~450
Development stage: Commercial

Overview

The Pirbright Institute conducts world-leading fundamental and applied research into viral diseases of livestock with major economic or zoonotic impact. It has developed vaccines, diagnostic tests, and surveillance tools that have contributed to the control of foot-and-mouth disease, bluetongue, avian flu outbreaks among others. Its work underpins global food security and public health preparedness.

Therapeutic areas: Infectious Diseases
Modalities: VaccineRecombinant proteinDiagnostic test
Industry: Academic Hospital/University/Research

Partnerships

DEFRA (UK Department for Environment Food & Rural Affairs)Wellcome TrustBill & Melinda Gates FoundationAcademic collaborations globally

Beyond the preview

Go deeper on The Pirbright Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Pirbright Institute.

Explore the full profile